Page last updated: 2024-10-31

mexiletine and Familial Periodic Paralysis

mexiletine has been researched along with Familial Periodic Paralysis in 4 studies

Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.

Research Excerpts

ExcerptRelevanceReference
"Skeletal muscle ion channelopathies are rare genetic diseases mainly characterized by myotonia (muscle stiffness) or periodic paralysis (muscle weakness)."3.01Drug repurposing in skeletal muscle ion channelopathies. ( Altamura, C; Campanale, C; Desaphy, JF; Laghetti, P; Saltarella, I, 2023)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Altamura, C2
Saltarella, I2
Campanale, C2
Laghetti, P2
Desaphy, JF3
Sah, RL1
Tsushima, RG1
Backx, PH1
De Luca, A1
Tortorella, P1
De Vito, D1
George, AL1
Conte Camerino, D1
Takahashi, MP1
Cannon, SC1

Reviews

1 review available for mexiletine and Familial Periodic Paralysis

ArticleYear
Drug repurposing in skeletal muscle ion channelopathies.
    Current opinion in pharmacology, 2023, Volume: 68

    Topics: Channelopathies; Dichlorphenamide; Drug Repositioning; Humans; Mexiletine; Muscle, Skeletal; Mutatio

2023
Drug repurposing in skeletal muscle ion channelopathies.
    Current opinion in pharmacology, 2023, Volume: 68

    Topics: Channelopathies; Dichlorphenamide; Drug Repositioning; Humans; Mexiletine; Muscle, Skeletal; Mutatio

2023
Drug repurposing in skeletal muscle ion channelopathies.
    Current opinion in pharmacology, 2023, Volume: 68

    Topics: Channelopathies; Dichlorphenamide; Drug Repositioning; Humans; Mexiletine; Muscle, Skeletal; Mutatio

2023
Drug repurposing in skeletal muscle ion channelopathies.
    Current opinion in pharmacology, 2023, Volume: 68

    Topics: Channelopathies; Dichlorphenamide; Drug Repositioning; Humans; Mexiletine; Muscle, Skeletal; Mutatio

2023

Other Studies

3 other studies available for mexiletine and Familial Periodic Paralysis

ArticleYear
Effects of local anesthetics on Na+ channels containing the equine hyperkalemic periodic paralysis mutation.
    The American journal of physiology, 1998, Volume: 275, Issue:2

    Topics: Anesthetics, Local; Animals; Benzocaine; Electrophysiology; Female; Horse Diseases; Horses; Hyperkal

1998
Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative.
    Neurology, 2001, Nov-27, Volume: 57, Issue:10

    Topics: Cell Line, Transformed; DNA Mutational Analysis; Dose-Response Relationship, Drug; Humans; Ion Chann

2001
Mexiletine block of disease-associated mutations in S6 segments of the human skeletal muscle Na(+) channel.
    The Journal of physiology, 2001, Dec-15, Volume: 537, Issue:Pt 3

    Topics: Binding, Competitive; Cell Line; Computer Simulation; Electric Stimulation; Humans; Ion Channel Gati

2001